DERM Earnings & Financial Statements
Journey Medical Corporation
$5.28
-$0.40(-7.04%)
33
Overall
20
Value
45
Tech
36
Quality
Market Cap
$149.02M
Volume
188.69K
52W Range
$4.31 - $9.56
Target Price
$13.75
DERM earnings and financial statements: Journey Medical Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
DERM Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $61.86M | $56.13M | $79.18M | $73.67M | $63.13M |
| Cost of revenue | $20.92M | $20.88M | $22.89M | $30.77M | $32.08M |
| Operating income | -$8.17M | -$13.68M | -$2.07M | -$27.52M | -$34.88M |
| EBITDA | -$2.86M | -$8.09M | $579.0K | -$23.18M | -$30.17M |
| Net income | -$11.43M | -$14.67M | -$3.85M | -$29.63M | -$43.99M |
| EPS (diluted) | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $94.59M | $80.24M | $76.85M | $105.16M | $97.28M |
| Total liabilities | $62.74M | $60.17M | $56.50M | $88.18M | $55.24M |
| Shareholders’ equity | $31.85M | $20.07M | $20.35M | $16.98M | $42.04M |
| Cash and equivalents | $24.09M | $20.30M | $27.44M | $32.00M | $49.08M |
| Long-term debt | $25.30M | $25.00M | $14.63M | $19.93M | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$12.44M | -$9.13M | $5.24M | -$13.53M | -$2.18M |
| Capital expenditure | - | -$15.00M | -$5.00M | -$20.00M | -$10.00M |
| Free cash flow | -$12.44M | -$24.13M | $240.0K | -$33.53M | -$2.18M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DERM | $5.28 | -7.0% | 188.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Journey Medical Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW